JP2024506999A5 - - Google Patents
Info
- Publication number
- JP2024506999A5 JP2024506999A5 JP2023571436A JP2023571436A JP2024506999A5 JP 2024506999 A5 JP2024506999 A5 JP 2024506999A5 JP 2023571436 A JP2023571436 A JP 2023571436A JP 2023571436 A JP2023571436 A JP 2023571436A JP 2024506999 A5 JP2024506999 A5 JP 2024506999A5
- Authority
- JP
- Japan
- Prior art keywords
- methylenediamine
- pharmaceutically acceptable
- pharmaceutical composition
- unit dosage
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144690P | 2021-02-02 | 2021-02-02 | |
| US63/144,690 | 2021-02-02 | ||
| PCT/US2022/014379 WO2022169690A1 (en) | 2021-02-02 | 2022-01-28 | Composition and methods for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506999A JP2024506999A (ja) | 2024-02-15 |
| JP2024506999A5 true JP2024506999A5 (https=) | 2024-12-16 |
Family
ID=82742455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571436A Pending JP2024506999A (ja) | 2021-02-02 | 2022-01-28 | がんを処置するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240099992A1 (https=) |
| EP (1) | EP4288040A4 (https=) |
| JP (1) | JP2024506999A (https=) |
| KR (1) | KR20230142733A (https=) |
| CN (1) | CN117083061A (https=) |
| AU (1) | AU2022218110A1 (https=) |
| CA (1) | CA3209477A1 (https=) |
| WO (1) | WO2022169690A1 (https=) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2560522A1 (en) * | 2003-03-26 | 2004-10-07 | Recepticon Aps | Use of compounds for the prevention of drug-induced cell toxicity |
| WO2007005643A2 (en) | 2005-07-01 | 2007-01-11 | Concert Pharmaceuticals Inc. | Novel aryloxyphenylpropanamines |
| WO2007005644A2 (en) | 2005-07-01 | 2007-01-11 | Concert Pharmaceuticals Inc. | Novel aryloxypropanamines |
| AU2006275702A1 (en) | 2005-07-29 | 2007-02-08 | Concert Pharmaceuticals Inc. | Novel pharmaceutical compounds |
| KR101380190B1 (ko) | 2005-07-29 | 2014-04-11 | 콘서트 파마슈티컬즈, 인크. | 벤조 〔ｄ〕〔１,３〕―디옥솔 유도체 |
| CN101426475A (zh) * | 2006-04-21 | 2009-05-06 | 安塔雷斯制药Ipl股份公司 | 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法 |
| JPWO2011002026A1 (ja) * | 2009-06-30 | 2012-12-13 | 国立大学法人 熊本大学 | アミロイド線維形成抑制剤及びその利用 |
| RU2417999C2 (ru) * | 2009-07-13 | 2011-05-10 | Закрытое Акционерное Общество "Ива Фарм" | БИЯДЕРНЫЕ КООРДИНАЦИОННЫЕ СОЕДИНЕНИЯ БИОЛОГИЧЕСКИ АКТИВНЫХ d-ЭЛЕМЕНТОВ С АЛИФАТИЧЕСКИМИ ТИОЛАМИ КАК СРЕДСТВА ПОВЫШЕНИЯ ЭФФЕКТИВНОСТИ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ |
| JP2011084541A (ja) * | 2009-10-19 | 2011-04-28 | Ltt Bio-Pharma Co Ltd | 低分子薬物含有ナノ粒子 |
| CA3064486C (en) | 2017-04-20 | 2023-08-01 | Geneheal Biotechnology Co., Ltd. | Applications of spermidine and its derivatives |
| GB201804924D0 (en) * | 2018-03-27 | 2018-05-09 | Univ Oxford Innovation Ltd | Radiolabelled compound |
-
2022
- 2022-01-28 JP JP2023571436A patent/JP2024506999A/ja active Pending
- 2022-01-28 CA CA3209477A patent/CA3209477A1/en active Pending
- 2022-01-28 EP EP22750212.7A patent/EP4288040A4/en active Pending
- 2022-01-28 KR KR1020237027432A patent/KR20230142733A/ko active Pending
- 2022-01-28 CN CN202280024006.5A patent/CN117083061A/zh active Pending
- 2022-01-28 US US18/272,939 patent/US20240099992A1/en active Pending
- 2022-01-28 AU AU2022218110A patent/AU2022218110A1/en active Pending
- 2022-01-28 WO PCT/US2022/014379 patent/WO2022169690A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537551A5 (https=) | ||
| JP2022009090A5 (https=) | ||
| JP2021527092A5 (https=) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| JP2023541430A5 (https=) | ||
| JP2014515373A5 (https=) | ||
| JP2022531898A5 (https=) | ||
| JP2012515184A (ja) | 大腸がんの治療方法 | |
| JP2018507243A5 (https=) | ||
| JP2021509395A5 (https=) | ||
| JP2008520544A5 (ja) | 癌関連疲労の治療または予防のための医薬の製造への使用方法 | |
| JP2019515909A5 (https=) | ||
| CN103533940A (zh) | 治疗晚期实体瘤的方法 | |
| JP2018531273A5 (https=) | ||
| JP2022508513A5 (https=) | ||
| JP2024016209A5 (https=) | ||
| JP2024517085A5 (https=) | ||
| JP2005512946A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| JP2022177119A5 (https=) | ||
| TW202128151A (zh) | 癌症治療方法 | |
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2024506999A5 (https=) | ||
| JP7357386B2 (ja) | 化合物又はその薬学的に許容される塩、二量体又は三量体のがん治療用医薬品の調製における応用 | |
| JP2021530568A5 (https=) |